Eiben T I, Fuhrmann V, Saugel B, Kluge S
Klinik für Intensivmedizin, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.
Klinik für Anästhesiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.
Internist (Berl). 2017 Mar;58(3):207-217. doi: 10.1007/s00108-017-0192-5.
Bleeding associated with hemorrhagic shock is often seen in emergency medical services or in the intensive care unit. Identifying the origin of the bleeding and additional disorders helps to determine the degree of the hemorrhagic shock. In order to be effective, the initial therapy until blood products are available needs to be differentiated to be effective in terms of hemodynamic stabilization and coagulation. Crystalloidal and colloidal solutions should be used carefully since those solutions bear a risk within themselves. Treatment of acidosis and hypothermia can further reduce bleeding complications. Early and repeated monitoring of clotting should be performed simultaneously to shock therapy to permit specific treatment and substitution of coagulation factors if needed. Hemorrhagic shock therapy should be continued until bleeding is stopped.
与失血性休克相关的出血常见于急诊医疗服务或重症监护病房。确定出血的源头及其他病症有助于判定失血性休克的程度。为确保有效性,在有血液制品可用之前的初始治疗需要在血流动力学稳定和凝血方面有所区分,以达到有效治疗。晶体溶液和胶体溶液应谨慎使用,因为这些溶液本身存在风险。酸中毒和体温过低的治疗可进一步减少出血并发症。应在休克治疗的同时尽早并反复进行凝血监测,以便在需要时进行特定治疗和凝血因子替代。失血性休克治疗应持续至出血停止。